Cost-utility of celecoxib use in different treatment strategies for osteoarthritis and rheumatoid arthritis from the Quebec healthcare system perspective

MLA

Bessette, Louis, et al. “Cost-Utility of Celecoxib Use in Different Treatment Strategies for Osteoarthritis and Rheumatoid Arthritis from the Quebec Healthcare System Perspective.” Journal of Medical Economics, vol. 12, no. 3, Jan. 2009, pp. 246–58. EBSCOhost, https://doi.org/10.3111/13696990903288970.

APA

Bessette, L., Risebrough, N., Mittmann, N., Roussy, J.-P., Ho, J., & Zlateva, G. (2009). Cost-utility of celecoxib use in different treatment strategies for osteoarthritis and rheumatoid arthritis from the Quebec healthcare system perspective. Journal of Medical Economics, 12(3), 246–258. https://doi.org/10.3111/13696990903288970

Chicago

Bessette, Louis, Nancy Risebrough, Nicole Mittmann, Jean-Pascal Roussy, Joanne Ho, and Gergana Zlateva. 2009. “Cost-Utility of Celecoxib Use in Different Treatment Strategies for Osteoarthritis and Rheumatoid Arthritis from the Quebec Healthcare System Perspective.” Journal of Medical Economics 12 (3): 246–58. doi:10.3111/13696990903288970.